ClinicalThought

Share

Program Content

Activities

  • Key Studies: ASH 2018
    Preview of Hot Topics at ASH 2018: Key Expert-Selected Studies
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 27, 2018

    Expires: November 26, 2019

  • ASH 2018: CAR-T
    CAR T-Cell Therapy in Lymphomas and Acute Lymphoblastic Leukemia: Exciting Data From ASH 2018
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 29, 2019

    Expires: April 27, 2020

Faculty

cover img faculity

John M. Burke, MD

Associate Chair
US Oncology Hematology Research Program
Rocky Mountain Cancer Centers
Aurora, Colorado

cover img faculity

Jeffrey P. DONOTUSESharman, MD

Medical Oncologist
Willamette Valley Cancer Institute and Research Center
Springfield, Oregon

cover img faculity

Daniel J. DeAngelo, MD, PhD

Professor of Medicine
Harvard Medical School
Chief, Division of Leukemia
Dana-Farber Cancer Institute
Boston, Massachusetts

cover img faculity

Shaji K. Kumar, MD

Mark and Judy Mullins Professor of Hematological Malignancies
Consultant, Division of Hematology
Professor of Medicine
Chair, Myeloma, Amyloidosis and Dysproteinemia Group
Research Chair, Division of Hematology
Mayo Clinic
Rochester, Minnesota

cover img faculity

Sagar Lonial, MD, FACP

Chair and Professor 
Department of Hematology and Medical Oncology
Anne and Bernard Gray Family Chair in Cancer
Chief Medical Officer
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia

cover img faculity

Keith W. Pratz, MD

Assistant Professor of Oncology
Division of Hematologic Malignancies
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland

cover img faculity

Farhad Ravandi, MD

Professor of Medicine
Department of Leukemia
University of Texas M. D. Anderson Cancer Center
Houston, Texas

Provided by

ProCE Banner

Supporters

AbbVie

AstraZeneca

Celgene

Dova Pharmaceuticals

Gilead Text

Incyte

Janssen Biotech Pharmacyclics Abbvie

Jazz Pharmaceuticals, Inc.

Novartis Pharmaceuticals Corporation

Seagen

Takeda Oncology